CD68- and CD163-positive tumor-associated macrophages in renal clear cell carcinoma

肾透明细胞癌中CD68和CD163阳性的肿瘤相关巨噬细胞

阅读:1

Abstract

This study aimed to analyze the infiltration of tumor-associated macrophages (TAMs) in clear cell renal cell carcinoma (ccRCC) and to assess their Prognostic significance. This study involved a Cohort of 106 patients with ccRCC who underwent partial or radical nephrectomy. Immunohistochemistry (IHC) was employed to assess the expression of two distinct types of macrophages at various tissue locations. The diagnostic utility of CD68-positive (CD68(+)) and CD163-positive (CD163(+)) macrophages was determined via Kaplan-Meier with log-rank tests and Multivariable Cox regression. Compared with those in adjacent tissues, the numbers of CD68(+) and CD163(+) TAMs were significantly elevated in ccRCC tissues. Kaplan-Meier analysis demonstrated that high CD163(+) TAM density was significantly associated with poorer overall survival (p = 0.006 in tumor nest, p = 0.043 in stroma), while CD68(+) TAMs showed no significant prognostic value (p > 0.4 for all comparisons). Multivariable Cox regression confirmed CD163(+) TAMs as independent prognostic factors after adjusting for tumor size and histological grade, with particularly strong association in tumor stroma (adjusted HR = 7.22, 95% CI 1.06-25.54, p = 0.003) compared to tumor nests (adjusted HR = 3.56, 95% CI 1.03-15.56, p = 0.045). TAMs, particularly the M2 subtype (CD163(+)), are identified as adverse prognostic factors for ccRCC patients. Those with a high density of M2 macrophages tend to have a poorer prognosis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。